Table 1 A detailed demographic and clinical profile of plasma donors
Group 1 Anti-D1(+) | Group 2 Anti-D1(−) | Group 3 Seronegative | |
|---|---|---|---|
Number of subjects | 6 | 6 | 6 |
Female/Male | 6/0 | 5/1 | 6/0 |
Age (years) | 35.8 (16–82) | 57.8 (27–76) | 41.1 (30–50) |
Clinical records | 1/6-SLE 4/5-thrombotic events 1/6-thrombocytopenia | 1/6-SLE 5/6-thrombotic events | – |
LA (number of positive patients) | 5/6 | 3/6 | 0/6 |
aCL (IgG) (U/ml) | 267.6 ± 399.1* | 61.10 ± 30.51 | < 20 |
aCL (IgM) (U/ml) | 67.17 ± 25.84 | 277.4 ± 263.2 | < 20 |
Anti-β2GPI (IgG) (U/ml) | 257.0 ± 220.8 | 167.9 ± 118.3 | < 20 |
Anti-β2GPI (IgM) (U/ml) | 73.83 ± 48.06 | 243.9 ± 173.7 | < 20 |
Anti-D1 β2GPI (CU/ml) | 106.8 ± 159.7 | < 20 | < 20 |